2009 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total Project Funding: | > 1000 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
2007 | |
Criterium: | Position: |
Overall Score: | 700-800 |
Total Project Funding per Partner: | 100-200 |
Total Number of Projects: | 400-500 |
Total Project Funding: | 100-200 |
Networking Rank (Reputation): | 400-500 |
Partner Constancy: | > 1000 |
Project Leadership Index: | 200-300 |
Diversity Index: | > 1000 |
Total funding allocated to projects this organisation participated or coordinated
Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
*Ratio includes only projects with > 2 partners
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 5.986.903 | 1.200.600 | 1 | ||
2012 | 0 | 5.986.490 | 75.030 | 1 |
Total number of partners:29
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 29
Frequent / Rare Partner Ratio: 0
Category: | No: |
---|---|
RTD HORIZONTAL TOPICS | 2 |
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-01-01 | Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial | HEPAMAB | participant | 5.986.903 | 7 |
2012-01-01 | Application of new technologies and methods in nutrition research – the example of phenotypic flexibility | NutriTech | participant | 5.986.490 | 24 |